Skip to main content
Premium Trial:

Request an Annual Quote

New Products: LifeCodexx's PraenaTest Express; Multiplicom's Mutation Detection Kits

Premium

GATC Biotech subsidiary LifeCodexx has launched a new version of its noninvasive fetal aneuploidy test, PraenaTest Express, that has a turnaround time of one week. The express version of the test will initially be available in Germany, and after a pilot phase will be introduced in other European countries, according to the company.


Multiplicom had launched three mutation-detection kits based on the company's proprietary MASTR technology. The three kits, which detect mutations common in gastrointestinal track, colon, lung, and skin cancers, can be used in combination with all next-gen sequencing systems.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.